DE3062976D1 - Tetrahydrocannabinol derivatives, 125i-labeled tetrahydrocannabinol derivatives, immunogens yielding antibodies and radioimmunoassay for detecting cannabinoids - Google Patents

Tetrahydrocannabinol derivatives, 125i-labeled tetrahydrocannabinol derivatives, immunogens yielding antibodies and radioimmunoassay for detecting cannabinoids

Info

Publication number
DE3062976D1
DE3062976D1 DE8080105800T DE3062976T DE3062976D1 DE 3062976 D1 DE3062976 D1 DE 3062976D1 DE 8080105800 T DE8080105800 T DE 8080105800T DE 3062976 T DE3062976 T DE 3062976T DE 3062976 D1 DE3062976 D1 DE 3062976D1
Authority
DE
Germany
Prior art keywords
tetrahydrocannabinol derivatives
tetrahydrocannabinol
derivatives
immunogens
radioimmunoassay
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
DE8080105800T
Other languages
English (en)
Inventor
Kenneth Earl Fahrenholtz
John Edward Heveran
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
F Hoffmann La Roche AG
Original Assignee
F Hoffmann La Roche AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by F Hoffmann La Roche AG filed Critical F Hoffmann La Roche AG
Application granted granted Critical
Publication of DE3062976D1 publication Critical patent/DE3062976D1/de
Expired legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D311/00Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/78Ring systems having three or more relevant rings
    • C07D311/80Dibenzopyrans; Hydrogenated dibenzopyrans
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/94Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving narcotics or drugs or pharmaceuticals, neurotransmitters or associated receptors
    • G01N33/948Sedatives, e.g. cannabinoids, barbiturates

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Hematology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Urology & Nephrology (AREA)
  • Biotechnology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • Cell Biology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Food Science & Technology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Anesthesiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pyrane Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DE8080105800T 1979-09-26 1980-09-25 Tetrahydrocannabinol derivatives, 125i-labeled tetrahydrocannabinol derivatives, immunogens yielding antibodies and radioimmunoassay for detecting cannabinoids Expired DE3062976D1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US7912579A 1979-09-26 1979-09-26

Publications (1)

Publication Number Publication Date
DE3062976D1 true DE3062976D1 (en) 1983-06-09

Family

ID=22148599

Family Applications (1)

Application Number Title Priority Date Filing Date
DE8080105800T Expired DE3062976D1 (en) 1979-09-26 1980-09-25 Tetrahydrocannabinol derivatives, 125i-labeled tetrahydrocannabinol derivatives, immunogens yielding antibodies and radioimmunoassay for detecting cannabinoids

Country Status (4)

Country Link
EP (1) EP0027567B1 (de)
JP (1) JPS5651471A (de)
CA (1) CA1182828A (de)
DE (1) DE3062976D1 (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5223441A (en) 1986-10-09 1993-06-29 Syntex (U.S.A.) Inc. Receptors for immune complexes
US6686209B2 (en) * 2001-03-12 2004-02-03 Lifepoint, Inc. Reagents for detecting cannabinoids
US7754188B2 (en) * 2003-06-30 2010-07-13 Merck Sharp & Dohme Corp. Radiolabeled cannabinoid-1 receptor modulators

Also Published As

Publication number Publication date
CA1182828A (en) 1985-02-19
EP0027567A1 (de) 1981-04-29
EP0027567B1 (de) 1983-05-04
JPS5651471A (en) 1981-05-09

Similar Documents

Publication Publication Date Title
DE3369887D1 (en) Digoxigenin immunogens, antibodies, labeled conjugates, and related derivatives
ZA771052B (en) Polyoxygenated labdane derivatives
ES516588A0 (es) Procedimiento para preparar derivados de piridona.
NO813208L (no) Fremgangsmaate for fremstilling av 3-aryl-5-isotiazol-derivater.
FI824314L (fi) Thienopyrimidin-derivater, deras framstaellning och deras medicinska anvaendning
YU324780A (en) Process for preparing 2-acylaminoethyl-1,4-benzo diazepines
HU182185B (en) Process for preparing 5-substituted 2,3-diaryl-thiophene derivatives
AU5913580A (en) Ergolinyl -n:,n:-diethylurea derivatives
MX6697E (es) Un procedimiento para preparar derivados de imido disulfamida
GR65234B (en) Method for the preparation new cefalosporimical derivatives
JPS52155206A (en) Super glazing machine for paper making machine
PH23776A (en) Thienopyridinone derivatives,process for their preparation
IL72835A0 (en) Immunogens,antibodies,labeled conjugates,and related derivatives for lidocaine and analogs thereof
GB1548222A (en) Trans-4-heterocyclyl-3,4-dihydro-2h-benzo pyarn-3-ol derivatives
ES506842A0 (es) Procedimiento para preparar derivados 3-aminopropoxifenili- cos.
HU175055B (hu) Sposob poluchenija novykh zameshchjonnykh proizvodnykh 2-fenil-amino-imidazol-2-ina
ZA818847B (en) New heterocyclic aminoalcoyl derivatives,the process for preparing same and the therapeutical use thereof
DE3062976D1 (en) Tetrahydrocannabinol derivatives, 125i-labeled tetrahydrocannabinol derivatives, immunogens yielding antibodies and radioimmunoassay for detecting cannabinoids
NZ191399A (en) 2-trichloromethyl (benzoxazine or quinazoline) derivatives
PT66312B (en) Process for preparing carbostyril derivatives
ES502026A0 (es) Un procedimiento para preparar derivados de tetrazolilcuma- rina
ES491577A0 (es) Un procedimiento para la preparacion de nuevos derivados de cromano.
ES495819A0 (es) Procedimiento de preparar derivados 1,2,4-oxadiazolin-5-oni-cos
ES508063A0 (es) "un procedimiento para preparar derivados de halofenil-piridil-alilamina".
ES502909A0 (es) Procedimiento de preparar derivados de quinoxalina-1,4-dio- xido

Legal Events

Date Code Title Description
8328 Change in the person/name/address of the agent

Free format text: LEDERER, F., DIPL.-CHEM. DR., PAT.-ANW., 8000 MUENCHEN

8339 Ceased/non-payment of the annual fee